Abe M. Macher
Armed Forces Institute of Pathology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Abe M. Macher.
The New England Journal of Medicine | 1986
Ira S. Cohen; David W. Anderson; Renu Virmani; Bernard M. Reen; Abe M. Macher; Joel Sennesh; Paul DiLorenzo; Robert R. Redfield
Infection with human immunodeficiency virus (HIV, or HTLV-III/LAV) results in global immune dysfunction and leads to a breakdown in the ability of the host to mount an immune response, thereby facilitating unremitting infections by predominantly opportunistic pathogens,1 2 3 4 with or without Kaposis sarcoma. These secondary events result in organ-system damage and in some cases in organ failure. To date, serious organ-system failure has been documented in the pulmonary, gastrointestinal, renal, and central nervous systems.4 5 6 Clinical cardiac involvement has received little attention except as a site of spread of Kaposis sarcoma.7 , 8 Recently, we observed three fatal cases of the acquired immunodeficiency syndrome .xa0.xa0.
Journal of the American College of Cardiology | 1988
David W. Anderson; Renu Virmani; Joseph M. Reilly; Timothy J. O'Leary; Robert E. Cunnion; Max Robinowitz; Abe M. Macher; Usha Punja; Siocgo T Villaflor; Joseph E. Parrillo; William C. Roberts
The prevalence of myocarditis was retrospectively evaluated in 71 consecutive necropsy patients who died from acquired immunodeficiency syndrome (AIDS) between 1982 and 1986. Myocarditis was found in 37 cases (52%). Biventricular dilation at necropsy was present in seven cases (10%) and was accompanied by myocarditis in each case; fatal congestive heart failure occurred in four of these seven cases. Although viral, protozoan, bacterial, fungal and mycobacterial opportunistic pathogens were present in myocardial sections of 7 of 37 myocarditis cases, the etiology of myocarditis in the majority of these patients with AIDS remained idiopathic. Thus, myocarditis is a frequent finding at necropsy in patients with AIDS and may contribute to the development of biventricular dilation.
The New England Journal of Medicine | 1995
Abe M. Macher; Eric Goosby
To the Editor: Noordhoek et al. (Dec. 30, 1993, issue)1 have raised serious questions1,2 about the reliability of the polymerase chain reaction (PCR) for the direct detection of Mycobacterium tuberculosis in clinical specimens. Nevertheless, commercial clinical laboratories continue to promote many PCR assays, even for use by correctional facilities. After a routine medical evaluation at the time of her entry into a state correctional facility, an asymptomatic 28-year-old woman had a 20-mm reaction to a purified-protein-derivative tuberculin skin test (Mantoux method). Her chest roentgenogram was normal. Three sputum specimens were collected on separate days for mycobacterial laboratory studies. Although .xa0.xa0.
American Journal of Clinical Pathology | 1987
Carlos Restrepo; Abe M. Macher; Eric H. Radany
American Heart Journal | 1988
Carmen Steigman; David W Anderson; Abe M. Macher; Joel Sennesh; Renu Virmani
Archives of Otolaryngology-head & Neck Surgery | 1988
Robert Colebunders; Henry Francis; Jonathan M. Mann; Kapita Bila; Kandi Kandi; Izaley Lebughe; P. L. J. Gigase; Erik Van Marck; Abe M. Macher; Thomas C. Quinn; James W. Curran; Peter Piot
Public Health Reports | 1994
Abe M. Macher; Eric Goosby; Barker L; Paul A. Volberding; Goldschmidt R; Balano Kb; Williams A; Hoenig L; Gould B; Daniels E
Military Medicine | 1987
Maria L. De Vinatea; Abe M. Macher; Robert J. Sbaschnig; Liselotte Hochholzer
American Journal of Respiratory and Critical Care Medicine | 1997
Abe M. Macher; Eric Goosby
Military Medicine | 1988
Peter Angritt; Abe M. Macher